News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
IASLC Highlights FDA Approval of VENTANA MET (SP44) RxDx Assay for NSCLC
Photo: Depositphotos
Jun 29, 2025, 13:27

IASLC Highlights FDA Approval of VENTANA MET (SP44) RxDx Assay for NSCLC

International Association for the Study of Lung Cancer shared a post on LinkedIn:

“VENTANA MET (SP44) RxDx Assay receives FDA approval as a companion diagnostic for telisotuzumab vedotin-tllv in patients with high c-MET overexpression in NSCLC.

Read more in ILCN.”

Read OncoDaily’s Special Article on NSCLC․

NSCLC Lung cancer

c-MET cancer IASLC International Association for the Study of Lung Cancer Lung cancer NSCLC OncoDaily Oncology
Special Coverage
Blog
Jul 20, 2025, 16:48
Jia (Jenny) Liu: Sharing Industry Insights from Recent Achievements on Quantitative Biomarkers
Blog
Jul 20, 2025, 15:58
New Study Finds Walking for an Hour a Day Improves Cancer Survival - ALK Positive
Insight
Jul 20, 2025, 15:44
Alok Khorana: Distinct Microbiotic Profiles of Early Onset Pancreatic Cancer
Blog
Jul 20, 2025, 15:38
Bill Gerber Passed away from an Aggressive and Malignant Brain Tumor - St. Baldrick's Foundation
Blog
Jul 20, 2025, 15:33
Ssemata Benjamin: Cancer Has No Boarders and Neither Should Our Fight Against It
Career
Jul 20, 2025, 15:24
Rasha Aboelhassan: Excited to Start Working as Educational Committee Member in IASLC
Career
Jul 20, 2025, 15:16
Lingbin Meng and Zachary Risch Receive The Ohio State University College of Medicine 2025 Research Innovation Career Development Awards
Blog
Jul 20, 2025, 15:08
Highlights From ANZUP 2025 Annual Scientific Meeting by Tian Zhang
Blog
Jul 20, 2025, 14:52
Priya Kumaravelu: I'm Happy to Start as President at American Association of Physicians of Indian Origin
Blog
Jul 20, 2025, 14:45
Emad Shash: 6 Abstracts Have Been Officially Accepted to the Prestigious ESMO 2025 Congress
Career
Jul 20, 2025, 14:31
Michael Jefford is a Finalist of the 2025 Patients Australia Awards Gala
Blog
Jul 20, 2025, 14:28
Sumanta Pal: The NCI Cooperative Groups are Addressing Clinically Relevant Questions for Agents Already in Use